These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20935564

  • 1. Lipid lowering with thyroid hormone and thyromimetics.
    Angelin B, Rudling M.
    Curr Opin Lipidol; 2010 Dec; 21(6):499-506. PubMed ID: 20935564
    [Abstract] [Full Text] [Related]

  • 2. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.
    Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD.
    Proc Natl Acad Sci U S A; 2008 Jan 15; 105(2):663-7. PubMed ID: 18160532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thyromimetics: a journey from bench to bed-side.
    Tancevski I, Rudling M, Eller P.
    Pharmacol Ther; 2011 Jul 15; 131(1):33-9. PubMed ID: 21504761
    [Abstract] [Full Text] [Related]

  • 5. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L, Li YL, Mellström K, Mellin C, Bladh LG, Koehler K, Garg N, Garcia Collazo AM, Litten C, Husman B, Persson K, Ljunggren J, Grover G, Sleph PG, George R, Malm J.
    J Med Chem; 2003 Apr 24; 46(9):1580-8. PubMed ID: 12699376
    [Abstract] [Full Text] [Related]

  • 6. The effect of thyroid disorders on lipid levels and metabolism.
    Duntas LH, Brenta G.
    Med Clin North Am; 2012 Mar 24; 96(2):269-81. PubMed ID: 22443975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thyroid receptor subtypes: structure and function in fish.
    Nelson ER, Habibi HR.
    Gen Comp Endocrinol; 2009 Mar 24; 161(1):90-6. PubMed ID: 18840444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight.
    Baxter JD, Webb P, Grover G, Scanlan TS.
    Trends Endocrinol Metab; 2004 Mar 24; 15(4):154-7. PubMed ID: 15109613
    [Abstract] [Full Text] [Related]

  • 11. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis.
    Ribeiro MO.
    Thyroid; 2008 Feb 24; 18(2):197-203. PubMed ID: 18279020
    [Abstract] [Full Text] [Related]

  • 12. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.
    Tancevski I, Demetz E, Eller P.
    Recent Pat Cardiovasc Drug Discov; 2011 Jan 24; 6(1):16-9. PubMed ID: 21208155
    [Abstract] [Full Text] [Related]

  • 13. Sobetirome: a case history of bench-to-clinic drug discovery and development.
    Scanlan TS.
    Heart Fail Rev; 2010 Mar 24; 15(2):177-82. PubMed ID: 19002578
    [Abstract] [Full Text] [Related]

  • 14. Design and characterization of a thyroid hormone receptor alpha (TRalpha)-specific agonist.
    Ocasio CA, Scanlan TS.
    ACS Chem Biol; 2006 Oct 24; 1(9):585-93. PubMed ID: 17168554
    [Abstract] [Full Text] [Related]

  • 15. Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia.
    Joharapurkar AA, Dhote VV, Jain MR.
    J Med Chem; 2012 Jun 28; 55(12):5649-75. PubMed ID: 22512468
    [No Abstract] [Full Text] [Related]

  • 16. General background on the hypothalamic-pituitary-thyroid (HPT) axis.
    Zoeller RT, Tan SW, Tyl RW.
    Crit Rev Toxicol; 2007 Jun 28; 37(1-2):11-53. PubMed ID: 17364704
    [Abstract] [Full Text] [Related]

  • 17. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
    Shiohara H, Nakamura T, Kikuchi N, Ozawa T, Nagano R, Matsuzawa A, Ohnota H, Miyamoto T, Ichikawa K, Hashizume K.
    Bioorg Med Chem; 2012 Jun 01; 20(11):3622-34. PubMed ID: 22542282
    [Abstract] [Full Text] [Related]

  • 18. Interactions between the melanocortin system and the hypothalamo-pituitary-thyroid axis.
    Martin NM, Smith KL, Bloom SR, Small CJ.
    Peptides; 2006 Feb 01; 27(2):333-9. PubMed ID: 16388877
    [Abstract] [Full Text] [Related]

  • 19. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future.
    Delitala AP, Delitala G, Sioni P, Fanciulli G.
    Curr Med Res Opin; 2017 Nov 01; 33(11):1985-1993. PubMed ID: 28498022
    [Abstract] [Full Text] [Related]

  • 20. The hypothalamic-pituitary-thyroid (HPT) axis in frogs and its role in frog development and reproduction.
    Fort DJ, Degitz S, Tietge J, Touart LW.
    Crit Rev Toxicol; 2007 Nov 01; 37(1-2):117-61. PubMed ID: 17364707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.